COSM

Cosmos Health Inc.

53
Fundamentals61/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential47/ 100

COSM lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

COSM Fundamentals

MetricStatus
Healthy
Under pressure
Weak
Weak

COSM's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.

COSM PE Valuation

COSM has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 2.1x next year's earnings.

COSM Forward outlook

MetricOutlook
--
Returning to profit
Strong growth
Strongly improving
Limited
Low

Analysts expect COSM to return to profit, with revenue growing. However, they disagree widely on these estimates.

COSM Risk to reward

ScenarioChangePrice
Upside+86%$0.39
Downside-48%$0.11

Calculated from the latest close: $0.21 on Nov 12.

COSM's one-year upside scenario is about twice its downside: +86% against −48%.

COSM Earnings Per Share

Q4 2023: $-2.15Q1 2024: $-2.22Q2 2024: $-2.28Q3 2024: $-2.46Q4 2024: $-1.17Q1 2025: $-1.09Q2 2025: $-1.04Q3 2025: $-0.76Q4 2025: $-0.63Q1 2026: $-0.66Q2 2026: $-0.66Forward: $0.10
Q4 2023: $-2.15Q1 2024: $-2.22Q2 2024: $-2.28Q3 2024: $-2.46Q4 2024: $-1.17Q1 2025: $-1.09Q2 2025: $-1.04Q3 2025: $-0.76Q4 2025: $-0.63Q1 2026: $-0.66Q2 2026: $-0.66Forward: $0.10
QuarterTTM EPSYoY
Forward$0.10—
Q2 2026-$0.66+$0.38
Q1 2026-$0.66+$0.43
Q4 2025-$0.63+$0.54
Q3 2025-$0.76+$1.70
Q2 2025-$1.04+$1.24
Q1 2025-$1.09+$1.13
Q4 2024-$1.17+$0.98
Q3 2021-$11.50-454%

COSM is still losing money, but far less than before: $0.66 per share over the past year, against $25.00 at its worst in late 2019.

COSM Quarterly Revenue

Q3 2023: $13MQ4 2023: $16MQ1 2024: $15MQ2 2024: $13MQ3 2024: $12MQ4 2024: $14MQ1 2025: $14MQ2 2025: $15MQ3 2025: $17MQ4 2025: $20MQ1 2026: $18MQ2 2026: $19M
Q3 2023: $13MQ4 2023: $16MQ1 2024: $15MQ2 2024: $13MQ3 2024: $12MQ4 2024: $14MQ1 2025: $14MQ2 2025: $15MQ3 2025: $17MQ4 2025: $20MQ1 2026: $18MQ2 2026: $19M
QuarterRevenueYoY
Q2 2026$19M+29%
Q1 2026$17.9M+31%
Q4 2025$19.7M+39%
Q3 2025$17.1M+38%
Q2 2025$14.7M+12%
Q1 2025$13.7M-6%
Q4 2024$14.2M-10%
Q3 2024$12.4M-3.2%

COSM's revenue has grown year over year for five quarters in a row: $19M last quarter, up 29% from the same quarter a year ago.

COSM Free Cash Flow

Q3 2023: −$5MQ4 2023: $905,022Q1 2024: −$3MQ2 2024: −$1MQ3 2024: $511,007Q4 2024: −$4MQ1 2025: −$198,846Q2 2025: −$1MQ3 2025: −$2MQ4 2025: −$5MQ1 2026: −$1MQ2 2026: −$2M
Q3 2023: −$5MQ4 2023: $905,022Q1 2024: −$3MQ2 2024: −$1MQ3 2024: $511,007Q4 2024: −$4MQ1 2025: −$198,846Q2 2025: −$1MQ3 2025: −$2MQ4 2025: −$5MQ1 2026: −$1MQ2 2026: −$2M
QuarterFree cash flowYoY
Q2 2026-$1.8M-$549.4K
Q1 2026-$1.1M-$879.6K
Q4 2025-$4.6M-$697.9K
Q3 2025-$2.5M-583%
Q2 2025-$1.2M+$12.6K
Q1 2025-$198.8K+$3.3M
Q4 2024-$3.9M-532%
Q3 2024$511K+$5.1M

COSM has burned cash in almost every quarter: −$10M over the past year, against −$5M the year before.

COSM Total Shares

Q3 2023: 13MQ1 2024: 17MQ2 2024: 18MQ3 2024: 18MQ1 2025: 26MQ2 2025: 29MQ3 2025: 31MQ1 2026: 47MQ2 2026: 60M
Q3 2023: 13MQ1 2024: 17MQ2 2024: 18MQ3 2024: 18MQ1 2025: 26MQ2 2025: 29MQ3 2025: 31MQ1 2026: 47MQ2 2026: 60M
PeriodChange %Net change
Quarterly+27%+12.8M shares
1 year+130%+33.9M shares
3 years+8337%+59.2M shares
5 years+11227%+59.4M shares

COSM has 60M diluted shares, up 130% from a year ago.

COSM Net Leverage

QuarterNet LeverageStatus
Q1 20218.5xHigh
Q4 20203.3xElevated
Q3 2020-0.3xNet Cash
Q2 2020-1.1xNet Cash
Q1 2020-1.9xNet Cash
Q4 20190.6xVery low

COSM's net debt is about 8.5 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.

COSM Weekly Momentum

MetricValueStatus
RSI40.5Neutral
Stochastic31.7Neutral

COSM's weekly RSI is 41 (neutral) and its Stochastic is 32 (neutral).

COSM PE vs Healthcare Sector

MetricCOSMSector medianRelative
PEN/A26x—

COSM has no meaningful PE right now: it lost money over the past year.

COSM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$0.3132% below
20 week MA$0.2722% below
50 week MA$0.3336% below
100 week MA$0.4957% below
200 week MA$1.1081% below

COSM is in a downtrend: it's below all five of its weekly moving averages, and 81% below its 200-week average.

COSM Yearly ROI

YearStart priceEnd priceROI
2020$62.5$127.5+104%
2021$127.5$99.0-22%
2022$99.0$6.40-94%
2023$6.40$1.41-78%
2024$1.41$0.68-52%
2025$0.68$0.51-25%
2026 YTD$0.51$0.21-59%

COSM has finished five years in a row lower, and it's down 59% so far in 2026.

Give your agent the market.

Get API key